Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Selective serotonin reuptake inhibitors in human pregnancy: to treat or not to treat?

Diav-Citrin O, Ornoy A.

Obstet Gynecol Int. 2012;2012:698947. doi: 10.1155/2012/698947.

2.

Selective serotonin reuptake inhibitors in human pregnancy: on the way to resolving the controversy.

Ornoy A, Koren G.

Semin Fetal Neonatal Med. 2014 Jun;19(3):188-94. doi: 10.1016/j.siny.2013.11.007. Review.

PMID:
24321501
3.

Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries.

Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M, Nielsen RB, Nørgaard M, Stephansson O, Valdimarsdottir U, Zoega H, Haglund B.

BMJ. 2012 Jan 12;344:d8012. doi: 10.1136/bmj.d8012.

4.

Selective serotonin reuptake inhibitors in pregnancy and infant outcomes.

Jefferies AL; Canadian Paediatric Society, Fetus and Newborn Committee..

Paediatr Child Health. 2011 Nov;16(9):562-3. English, French.

5.

Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs).

Ellfolk M, Malm H.

Reprod Toxicol. 2010 Sep;30(2):249-60. doi: 10.1016/j.reprotox.2010.04.015. Review.

PMID:
20447455
6.
7.

Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.

Tuccori M, Montagnani S, Testi A, Ruggiero E, Mantarro S, Scollo C, Pergola A, Fornai M, Antonioli L, Colucci R, Corona T, Blandizzi C.

Postgrad Med. 2010 Jul;122(4):49-65. doi: 10.3810/pgm.2010.07.2175. Review.

PMID:
20675971
8.

Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.

Cantor Sackett J, Weller RA, Weller EB.

Curr Psychiatry Rep. 2009 Jun;11(3):253-7. Review.

PMID:
19470288
9.

Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects.

Alwan S, Reefhuis J, Rasmussen SA, Olney RS, Friedman JM; National Birth Defects Prevention Study..

N Engl J Med. 2007 Jun 28;356(26):2684-92.

10.

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.

Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M.

Clin Ther. 2009 Jun;31 Pt 1:1426-53. doi: 10.1016/j.clinthera.2009.07.009. Review.

PMID:
19698902
11.

[Selective serotonin reuptake inhibitors (SSRIs) in pregnancy].

Tango R, Berney P, Schulz P.

Rev Med Suisse. 2006 Apr 12;2(61):981-5. Review. French.

PMID:
16686331
12.

Risks associated with selective serotonin reuptake inhibitors in pregnancy.

Malm H, Klaukka T, Neuvonen PJ.

Obstet Gynecol. 2005 Dec;106(6):1289-96.

PMID:
16319254
13.

ACOG Committee Opinion No. 354: Treatment with selective serotonin reuptake inhibitors during pregnancy.

ACOG Committee on Obstetric Practice..

Obstet Gynecol. 2006 Dec;108(6):1601-3.

PMID:
17138801
14.

Safety of newer antidepressants in pregnancy.

Way CM.

Pharmacotherapy. 2007 Apr;27(4):546-52. Review.

PMID:
17381382
15.

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, Mitchell AA.

N Engl J Med. 2006 Feb 9;354(6):579-87.

16.

Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis.

Kornum JB, Nielsen RB, Pedersen L, Mortensen PB, Nørgaard M.

Clin Epidemiol. 2010 Aug 9;2:29-36.

17.

Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations.

Wogelius P, Nørgaard M, Gislum M, Pedersen L, Munk E, Mortensen PB, Lipworth L, Sørensen HT.

Epidemiology. 2006 Nov;17(6):701-4.

PMID:
17028507
18.

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

Oberlander TF, Misri S, Fitzgerald CE, Kostaras X, Rurak D, Riggs W.

J Clin Psychiatry. 2004 Feb;65(2):230-7.

PMID:
15003078
19.

Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.

Davis RL, Rubanowice D, McPhillips H, Raebel MA, Andrade SE, Smith D, Yood MU, Platt R; HMO Research Network Center for Education, Research in Therapeutics..

Pharmacoepidemiol Drug Saf. 2007 Oct;16(10):1086-94. Review.

PMID:
17729378
20.

Safety of selective serotonin reuptake inhibitors in pregnancy.

Alwan S, Friedman JM.

CNS Drugs. 2009;23(6):493-509. doi: 10.2165/00023210-200923060-00004. Review.

PMID:
19480468
Items per page

Supplemental Content

Support Center